app

(redirected from Abeta)
Also found in: Medical, Financial, Encyclopedia.

APP

abbr.
amyloid precursor protein

app

 (ăp)
n.
A computer application.

[Short for application.]

app

(æp)
n
(Computer Science) computing (esp downloaded to a mobile device) short for application program

app

(æp)
n.
Computers (informal). an application program; application software.
[1985–90]

app.

1. apparatus.
2. apparent.
3. appendix.
4. applied.
5. appointed.
6. approved.
7. approximate.
References in periodicals archive ?
Leptin's dual action mechanism (targeting abeta and tau) may provide an advantage over therapies with single mechanism, says Lex Van der Ploeg", CSO at Rhythm and Director at Neurotez.
Craft said, "If insulin were administered before the oligomeric Abeta, the dendritic spines were protected.
Any customers using an AbetA till solution can also benefit from event file sharing.
Autoantibodies are now attracting significant interest in the AD field, with more than twenty types identified and studied, notably relating to Abeta.
Amyloid beta peptide, or Abeta, is believed to start the cascade of events that leads to brain cell damage and death in Alzheimer's: as levels increase, the peptide starts clumping in the brain.
Rather than lowering amyloid beta (Abeta) levels, as two failed investigational drugs--tramiprosate and taren-flurbil--have attempted, dimebon appears to almost immediately increase them, raising Abeta by as much as 200% in three mouse models of Alzheimer's disease (AD), Dr.
Chris Latter, from exhibitors ABetA, was first to reserve space for 2010, saying: "I'm well pleased.
Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC (2000) Identification of the major Abeta 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition.
While considerable effort has focused on Abeta and tau related markers, a substantial number of other molecules and parameters have been identified, that may offer opportunities.
For example, there are a number of candidate biomarkers relating to Abeta, which are discussed in the context of Abeta targeting drugs.
But Var IV can't make the connection, possibly disturbing Abeta processing.
Exhibitors include SIS (which will feature the Racing Post's digital Betting Shop Display), Alphameric, AbetA, Diamond Projects, bgbet, Aspen Concepts, Diamond Signs & Services, MRG and Durrington Fine Arts.